Besides, RIP assay results disclosed that SNHG10 exhibited strong enrichment in Ago2 group relative to IgG group (Fig. 3c), implying that SNHG10 might function as a ceRNA in glioma. The gene discussed is AGO2; the disease is central nervous system cancer.